Importantly, Rspo2 neutralization or Wnt/β-catenin inhibition effectively inhibited synovial inflammation, synovial hyperplasia, and cartilage degradation to attenuate the progression of RA. Here, RSPO2 is linked to rheumatoid arthritis.